This company develops minimally invasive neuromodulation devices for treating obstructive sleep apnea (OSA). Their technology aims to provide an alternative to traditional OSA treatments like CPAP machines.
Funding
Funding not disclosed
Founders
Product
Problem
Obstructive sleep apnea (OSA) is commonly treated with continuous positive airway pressure (CPAP) machines, which can be uncomfortable and lead to poor patient compliance. Many individuals seek alternative, less invasive treatment options for managing their OSA.
Solution
VivaMed Inc. develops minimally invasive neuromodulation devices designed to treat obstructive sleep apnea. Their technology offers an alternative to traditional CPAP therapy by stimulating the hypoglossal nerve. This stimulation helps to maintain an open airway during sleep, reducing apneas and improving sleep quality. The company aims to provide a more comfortable and convenient solution for individuals suffering from OSA.
Target Audience
The primary target audience includes individuals diagnosed with obstructive sleep apnea who are seeking alternatives to CPAP machines.
Features
- Minimally invasive surgical procedure for device implantation
- Hypoglossal nerve stimulation to maintain airway patency
- Alternative to traditional CPAP therapy